ABIN335355
antibody from antibodies-online
Targeting: MUC1
ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN335355 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN335355, RRID:AB_10769122
- Product name
- anti-Mucin 1, Cell Surface Associated (MUC1) antibody
- Antibody type
- Monoclonal
- Antigen
- GP1.4 is a mouse monoclonal IgG1 antibody derived by fusion of mouse myeloma cells with spleen cells from a mouse immunized with human milk fat globule.
- Description
- Prepared from rabbit serum by affinity purification on a column made with the peptide antigen.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- GP1-4
- Vial size
- 100 μg
- Storage
- 4°C
Submitted references New immunoassays for MUC1 in breast cancer.
Carcinoma-associated MUC1 detected by immunoradiometric assays.
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
Norum LF, Sauren AM, Rye PD, Nustad K
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001 Jul-Aug;22(4):216-22
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001 Jul-Aug;22(4):216-22
Carcinoma-associated MUC1 detected by immunoradiometric assays.
Norum LF, Varaas T, Kierulf B, Nustad K
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19 Suppl 1:134-46
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19 Suppl 1:134-46
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV, Kenemans P, van Kamp GJ, Verstraeten AA, Hilgers J
British journal of cancer 1995 Oct;72(4):934-8
British journal of cancer 1995 Oct;72(4):934-8
No comments: Submit comment
No validations: Submit validation data